Interactions of Antiepileptic Drugs (Q39336953)

11 September 2017

Interactions of antiepileptic drugs (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A50232

7 April 2022

Interactions of Antiepileptic Drugs (English)

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

7 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

7 April 2022

author name string

H. Kutt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A50232

7 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=50232

7 April 2022

publication date

1 June 1975

1 reference

full work available at URL

11 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1528-1157.1975.tb06065.x

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1528-1157.1975.tb06065.x/fullpdf

7 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

7 April 2022

1 reference

11 September 2017

16

1 reference

11 September 2017

2

1 reference

11 September 2017

393-402

1 reference

Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1975.TB06065.X

Metabolism in vitro of 5,5-diphenylhydantoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1975.TB06065.X

Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1975.TB06065.X

Biochemical and genetic factors regulating dilantin metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1975.TB06065.X

Drug interactions: effect of methylphenidate on the disposition of diphenylhydantoin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1975.TB06065.X

Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1975.TB06065.X

The simultaneous determination of multiple anticonvulsant drug levels by gas-liquid chromatography. Method and clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1975.TB06065.X

Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in man

21 January 2018

1

14

231

Ambre JJ

1973

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Phenylethylmalonamide (PEMA). An important metabolite of primidone

7 April 2022

2

27

34

Baumel IP

1972

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Factors involved in an outbreak of phenytoin intoxication

7 April 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Concurrent administration of phenobarbital and diphenylhydantoin: lack of an interference effect

7 April 2022

4

21

383

Booker HE

1971

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Preliminary observations of serum carbamazepine concentration in epileptic patients

7 April 2022

8

23

357

Cereghino JJ

1973

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Inhibition of drug metabolism by chloramphenicol

7 April 2022

9

2

1397

Christensen LK

1969

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

7 April 2022

Pharmacological Reviews

10

19

317

Conney AH.

1967

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

DRUG INTERACTIONS IN MAN. I. LOWERING EFFECT OF PHENOBARBITAL ON PLASMA LEVELS OF BISHYDROXYCOUMARIN (DICUMAROL) AND DIPHENYLHYDANTOIN (DILANTIN)

7 April 2022

11

6

420

Cucinell SA

1965

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Effect of anticonvulsant drugs on dicophane (D.D.T.) residues in man

7 April 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

A Clinical Study of the Effect of Phenobarbital on Diphenylhydantoin Plasma Levels

7 April 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Phenytoin (Dilantin) intoxication

7 April 2022

16

43

440

Fincham RW

1967

0 references

Disappearance of phenobarbital and diphenylhydantoin from serum of children

19

11

674

Garrettson LK

1970

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults

7 April 2022

21

287

900

Hahn TJ

1972

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Dicoumarol-induced diphenylhydantoin intoxication

7 April 2022

22

2

265

Hansen JM

1966

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.

7 April 2022

23

9

17

Hansen JM

1968

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man

7 April 2022

25

12

539

Hansen JM

1971

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Studies on dexamethasone metabolism in man: effect of diphenylhydantoin

7 April 2022

26

34

44

Haque N.

1972

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

7 April 2022

27

5

705

Hirschmann J.

1969

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Increased Rate of Clearance of Drugs from the Circulation of Alcoholics*

7 April 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Phenytoin intoxication during treatment with antabuse (Disulfiram)

7 April 2022

29

7

246

Kiorboe E.

1966

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy

7 April 2022

30

16

594

Kutt H.

1966

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes

7 April 2022

31

19

611

Kutt H.

1969

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution

7 April 2022

36

11

846

Kupferberg HJ

1970

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.

7 April 2022

37

29

1553

Meikle AW

1969

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Disulfiramum (antabuse) as inhibitor of phenytoin metabolism

7 April 2022

Disturbance of Calcium Metabolism by Anticonvulsant Drugs

41

volume

24

0 references

44

4

73

Richens A.

1970

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Alcoholism, Alcohol, and Drugs

7 April 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Improved Control of Epilepsy by Monitoring Plasma Ethosuximide

7 April 2022

49

28

178

Sherwin AL

1973

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

The effect of phenyramidol on the metabolism of diphenylhydantoin

7 April 2022

50

8

554

Solomon HM

1967

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Interactions between digitoxin and other drugs in vitro and in vivo

7 April 2022

51

79

362

Solomon HM

1971

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy

7 April 2022

53

77

389

Sotaniemi EA

1972

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Interaction between phenytoin and the benzodiazepines

7 April 2022

54

1

346

Vajda FJE

1971

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Serum organochlorine pesticides in mentally retarded patients on differing drug regimens

7 April 2022

55

13

186

Vesell ES

1972

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

Cortisol production in epileptic patients treated with diphenylhydantoin

7 April 2022

56

12

698

Werk EE

1971

1 reference

https://api.crossref.org/works/10.1111/J.1528-1157.1975.TB06065.X

7 April 2022

Identifiers

1 reference

11 September 2017

1 reference